These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4811224)

  • 1. Alkaloid studies. 9. Preparation of 18-acylyohimban-17-ones and their conversion to new heterocyclic yohimbans.
    Albright JD; Goldman L
    J Med Chem; 1974 Mar; 17(3):296-300. PubMed ID: 4811224
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkaloid studies. 7. Reactions of 18-hydroxymethyleneyohimban-17-one and the preparation of yohimbano(17,18-c and 18,17-d)pyrazoles.
    Albright JD; Conroy NH; Goldman L; Osterberg AC
    J Med Chem; 1971 Jul; 14(17):571-4. PubMed ID: 5164445
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and central nervous system depressant activity of new oxaza heterocyclic amides.
    Pifferi G; Consonni P; Diena A; Rosselli del Turco B
    J Med Chem; 1972 Aug; 15(8):851-3. PubMed ID: 5044302
    [No Abstract]   [Full Text] [Related]  

  • 4. 1-Substituted-3-aminoalkoxy-4,5-cycloalkylpyrazoles with central nervous system depressant activity.
    Barbaz BS; Chernov HI; Finch N; Gschwend HW; Hamdan A
    J Med Chem; 1972 Oct; 15(10):1027-9. PubMed ID: 5069769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Actions of rauvanine, an alkaloid of Rauwolfia vomitora Afz. on the central nervous system in mice].
    Quevauviller A; Sarrazin G; Takenaka Y
    Ann Pharm Fr; 1972 Jan; 30(1):45-9. PubMed ID: 5043667
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and central nervous system depressant activity of some 5-(2-substituted alkyl)-2-oxazolidinones.
    Fielden ML; Welstead WJ; Dawson ND; Chen YH; Mays RP; DaVanzo JP; Lunsford CD
    J Med Chem; 1973 Oct; 16(10):1124-8. PubMed ID: 4795992
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-(2-Aminoethyl)-2-oxazolidinones with central nervous system depressant and antiinflammatory activity.
    Welstead WJ; Helsley GC; Taylor CR; Turnbull LB; DaVanzo JP; Funderburk WH; Alphin RS
    J Med Chem; 1973 Oct; 16(10):1129-32. PubMed ID: 4795993
    [No Abstract]   [Full Text] [Related]  

  • 8. [3,4,5-trimethoxybenzamides. IV. - Synthesis of the new trimethoxybenzoyloxazolidine].
    Parravicini F; Pinza M; Ventura P; Banfi S; Pifferi G
    Farmaco Sci; 1976 Jan; 31(1):49-57. PubMed ID: 939319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tricyclic systems. Oxazole, thiazole, and imidazole analogs of the amitriptyline type.
    Galantay EE; Simpson R; Corriveau G; Denzer M; Knorr DC; Strohschein RJ; Paolella NA; Uike Y
    J Med Chem; 1974 Dec; 17(12):1316-27. PubMed ID: 4427328
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyrazolodiazepines. 1,3-(And 2,3-) dialkyl-4,6-dihydro-8-arylpyrazolo(4,3-e)(1,4)diazepin-5-ones as antianxiety agents.
    DeWald HA; Nordin IC; L'Italien YJ; Parcell RF
    J Med Chem; 1973 Dec; 16(12):1346-54. PubMed ID: 4765860
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of Rauwolfia vomitoria and chlorpromazine on locomotor behaviour and anxiety in mice.
    Bisong SA; Brown R; Osim EE
    J Ethnopharmacol; 2010 Oct; 132(1):334-9. PubMed ID: 20800668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of compounds with potential central nervous system stimulant activity. II. 5-spiro-substituted 2-amino-2-oxazolines.
    Harnden MR; Rasmussen RR
    J Med Chem; 1970 Mar; 13(2):305-8. PubMed ID: 5418511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of serpasil on the central nervous system].
    EDERLE W
    Nervenarzt; 1956 Jan; 27(1):33. PubMed ID: 13297088
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the syntheses of heterocyclic compounds. 459. Synthesis of rescinnamine-like compounds as antihypertensive agents.
    Kametani T; Ihara M; Suzuki T; Takahashi T; Iwaki R
    J Med Chem; 1972 Jun; 15(6):686-7. PubMed ID: 4402290
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the action of rescinnamine (reserpinine) on the central nervous system].
    Schmitt H; Nechtschein S; Gonnard P
    J Physiol (Paris); 1958; 50(1):75-89. PubMed ID: 13539813
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropharmacological aspects of reserpine.
    SCHNEIDER JA; PLUMMER AJ; EARL AE; GAUNT R
    Ann N Y Acad Sci; 1955 Apr; 61(1):17-26. PubMed ID: 14377269
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of selected central mechanisms for the analysis of the action of reserpine.
    BEIN HJ
    Ann N Y Acad Sci; 1955 Apr; 61(1):4-16. PubMed ID: 14377268
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of some substituted phenanthrenes on the central nervous system.
    Roszkowski AP; Schuler ME; Nelson PH
    J Med Chem; 1972 Dec; 15(12):1336-8. PubMed ID: 4635985
    [No Abstract]   [Full Text] [Related]  

  • 19. Bicyclic Mannich bases. 1. Psychotropic activity of 2-(4-aryl-1-piperazinyl)bicyclo(3.3.1)nonan-9-ones and derivatives.
    Schut RN; Ward FE; Rodriguez R
    J Med Chem; 1972 Mar; 15(3):301-4. PubMed ID: 5062072
    [No Abstract]   [Full Text] [Related]  

  • 20. [Derivatives of 5-hydroxymethylen-cis-4-caranone].
    Bondavalli F; Schenone P; Longobardi M
    Farmaco Sci; 1974 Jan; 29(1):48-57. PubMed ID: 4426372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.